Who
Jennifer L. Callahan
EVP and CFO
Company insider
Files Form 4 as: EVP and CFO, Cingulate.
In numbers
- Trades disclosed
- 34
- Buys
- 11
- Sells
- 0
- Bought
- $98K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Dec 2021
- Last trade
- 16 Jul 2026
- Last filed
- 20 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,200 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,800 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,200 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,800 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code A | —15,329 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code F | —6,427 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code A | —15,329 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code F | —6,427 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING CingulateBiotechnology | SEC FORM 4 Bought | $25K4,864 at $5.04 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $3893,891 at $0.10 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $3893,891 at $0.10 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING CingulateBiotechnology | SEC FORM 4 Bought | $25K4,864 at $5.04 | filing |
| 7 Jul 2025filed 9 Jul 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —64,500 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,140 at $0.00 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,539 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —94,986 at $0.00 | filing |
| 4 Mar 2024filed 6 Mar 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,014 at $0.00 | filing |
| 15 Sep 2023filed 18 Sep 2023 | CING CingulateBiotechnology | SEC FORM 4 Bought | $3,3505,000 at $0.67 | filing |
| 15 May 2023filed 16 May 2023 | CING CingulateBiotechnology | SEC FORM 4 Bought | $2,0202,000 at $1.01 | filing |
| 12 May 2023filed 16 May 2023 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $1131,030 at $0.11 | filing |
News
No headline names them, or the companies they trade most, lately.